Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q2 EPS of ($0.27), $0.12 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
• Walmart shares fall despite earnings beat
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance